Simtra BioPharma Appoints Dr. Mike Schaefers as Chief Commercial Officer

Simtra BioPharma Solutions, a leading contract development and manufacturing organization (CDMO) specializing in sterile injectables, has announced the appointment of Dr. Mike Schaefers, Ph.D., as its new Chief Commercial Officer and Head of Business Development. In this key role, Schaefers will be responsible for overseeing global commercial operations, driving business growth, strengthening customer relationships, and spearheading the company's market expansion initiatives.

“Dr. Mike Schaefers brings a unique combination of strategic insight and practical operational expertise,” said Franco Negron, CEO of Simtra BioPharma Solutions. “His deep understanding of the industry will be instrumental in our efforts to expand our market presence and deliver exceptional value to our clients.”

Dr. Schaefers joins Simtra BioPharma with extensive experience in leadership roles at prominent organizations, including LTS Lohmann Therapie-Systeme AG, Aenova Holding GmbH, and West Pharmaceutical Services. At LTS, he served as Chief Commercial Officer, where he managed a global team across Germany, the U.S., and China. His career is marked by successful strategies that drove business growth, managed key partnerships, and led significant acquisitions and integration efforts.

Holding a Ph.D. in Inorganic Chemistry from Ruhr University Bochum, Schaefers has also completed executive leadership programs and remains an active member of various industry associations.

“I am excited to join Simtra BioPharma Solutions during such a pivotal period of growth,” said Schaefers. “I look forward to collaborating with the talented team here to build on Simtra’s success and contribute to the company’s continued excellence in the CDMO sector.”